178 related articles for article (PubMed ID: 22503225)
1. Two-wavelength near-infrared fluorescence for the quantitation of drug antiplatelet effects in large animal model systems.
Ashitate Y; Kim SH; Tanaka E; Henary M; Choi HS; Frangioni JV; Flaumenhaft R
J Vasc Surg; 2012 Jul; 56(1):171-80. PubMed ID: 22503225
[TBL] [Abstract][Full Text] [Related]
2. Localization and quantification of platelet-rich thrombi in large blood vessels with near-infrared fluorescence imaging.
Flaumenhaft R; Tanaka E; Graham GJ; De Grand AM; Laurence RG; Hoshino K; Hajjar RJ; Frangioni JV
Circulation; 2007 Jan; 115(1):84-93. PubMed ID: 17179017
[TBL] [Abstract][Full Text] [Related]
3. Cilostazol down-regulates the height of mural platelet thrombi formed under a high-shear rate flow in the absence of ADAMTS13 activity.
Yagi H; Yamaguchi N; Shida Y; Hayakawa M; Matsumoto M; Sugimoto M; Wada H; Tsubaki K; Fujimura Y
Eur J Pharmacol; 2012 Sep; 691(1-3):151-5. PubMed ID: 22796451
[TBL] [Abstract][Full Text] [Related]
4. Real-time assessment of cardiac perfusion, coronary angiography, and acute intravascular thrombi using dual-channel near-infrared fluorescence imaging.
Tanaka E; Chen FY; Flaumenhaft R; Graham GJ; Laurence RG; Frangioni JV
J Thorac Cardiovasc Surg; 2009 Jul; 138(1):133-40. PubMed ID: 19577070
[TBL] [Abstract][Full Text] [Related]
5. Cilostazol could ameliorate platelet responsiveness to clopidogrel in patients undergoing primary percutaneous coronary intervention.
Kim JY; Lee K; Shin M; Ahn M; Choe H; Yoo BS; Yoon J; Choe KH; Lee SH
Circ J; 2007 Dec; 71(12):1867-72. PubMed ID: 18037738
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory Effects of Aspirin and Cilostazol on Intracellular Ca
Sone A; Aki K; Yasui T; Hosoi E
J Med Invest; 2023; 70(1.2):94-100. PubMed ID: 37164750
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of effects of various drugs on platelet functions using phorbol 12-myristate 13-acetate-induced megakaryocytic human erythroid leukemia cells.
Tada T; Aki K; Oboshi W; Kawazoe K; Yasui T; Hosoi E
Drug Des Devel Ther; 2016; 10():3099-3107. PubMed ID: 27713620
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet effect of aspirin in patients with coronary artery disease.
Grove EL
Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
[TBL] [Abstract][Full Text] [Related]
9. Comparison of on-treatment platelet reactivity between triple antiplatelet therapy with cilostazol and standard dual antiplatelet therapy in patients undergoing coronary interventions: a meta-analysis.
Panchal HB; Shah T; Patel P; Albalbissi K; Molnar J; Coffey B; Khosla S; Ramu V
J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):533-43. PubMed ID: 23872509
[TBL] [Abstract][Full Text] [Related]
10. Pancreas-targeted NIR fluorophores for dual-channel image-guided abdominal surgery.
Wada H; Hyun H; Vargas C; Gravier J; Park G; Gioux S; Frangioni JV; Henary M; Choi HS
Theranostics; 2015; 5(1):1-11. PubMed ID: 25553094
[TBL] [Abstract][Full Text] [Related]
11. Effects of antiplatelet agents on pulmonary haemodynamic response to fMLP in endotoxin primed rats.
Song C; Suzuki S; Kubo H; Chida M; Hoshikawa Y; Tabata T; Kondo T
Thorax; 2004 Jan; 59(1):39-44. PubMed ID: 14694246
[TBL] [Abstract][Full Text] [Related]
12. Effect on platelet function of cilostazol, clopidogrel, and aspirin, each alone or in combination.
Comerota AJ
Atheroscler Suppl; 2005 Dec; 6(4):13-9. PubMed ID: 16275168
[TBL] [Abstract][Full Text] [Related]
13. Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy According to Gene Polymorphism) study.
Kim IS; Jeong YH; Park Y; Yoon SE; Kwon TJ; Park JR; Hwang SJ; Koh EH; Kwak CH; Hwang JY; Kim S
Br J Clin Pharmacol; 2012 Apr; 73(4):629-40. PubMed ID: 22007612
[TBL] [Abstract][Full Text] [Related]
14. In vivo near infrared fluorescence (NIRF) intravascular molecular imaging of inflammatory plaque, a multimodal approach to imaging of atherosclerosis.
Calfon MA; Rosenthal A; Mallas G; Mauskapf A; Nudelman RN; Ntziachristos V; Jaffer FA
J Vis Exp; 2011 Aug; (54):. PubMed ID: 21847078
[TBL] [Abstract][Full Text] [Related]
15. Effect of cilostazol on platelet aggregation and experimental thrombosis.
Kimura Y; Tani T; Kanbe T; Watanabe K
Arzneimittelforschung; 1985; 35(7A):1144-9. PubMed ID: 4074426
[TBL] [Abstract][Full Text] [Related]
16. Impact of Multidrug Resistance Protein-4 Inhibitors on Modulating Platelet Function and High on-Aspirin Treatment Platelet Reactivity.
Alemanno L; Massimi I; Klaus V; Guarino ML; Maltese T; Frati L; Angiolillo DJ; Pulcinelli FM
Thromb Haemost; 2018 Mar; 118(3):490-501. PubMed ID: 29448294
[TBL] [Abstract][Full Text] [Related]
17. Deep learning for in vivo near-infrared imaging.
Ma Z; Wang F; Wang W; Zhong Y; Dai H
Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33372162
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic effects of a platelet fibrinogen receptor antagonist in a canine model of carotid artery thrombosis.
Willette RN; Sauermelch CF; Rycyna R; Sarkar S; Feuerstein GZ; Nichols AJ; Ohlstein EH
Stroke; 1992 May; 23(5):703-11. PubMed ID: 1605806
[TBL] [Abstract][Full Text] [Related]
19. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.
Jeong YH; Hwang JY; Kim IS; Park Y; Hwang SJ; Lee SW; Kwak CH; Park SW
Circ Cardiovasc Interv; 2010 Feb; 3(1):17-26. PubMed ID: 20118150
[TBL] [Abstract][Full Text] [Related]
20. Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery.
Kohda N; Tani T; Nakayama S; Adachi T; Marukawa K; Ito R; Ishida K; Matsumoto Y; Kimura Y
Thromb Res; 1999 Nov; 96(4):261-8. PubMed ID: 10593428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
